Dose-dependent Antithrombotic effects of apixaban, an oral direct factor Xa inhibitor, in prevention and treatment of thrombosis in rabbit models of arteriovenous-shunt and venous thrombosis at doses that preserve hemostasis

被引：1
|
作者：
Wong, Pancras C. [1 ]
Crain, Earl J. [1 ]
Pinto, Donald [1 ]
Watson, Carol A. [1 ]
机构：
[1] Bristol Myers Squibb Co, Pennington, NJ USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.933.933
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
933
引用
收藏
页码：283A / 283A
页数：1
相关论文
共 26 条
  • [1] Evaluation of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasis
    Schumacher, W. A.
    Bostwick, J. S.
    Stewart, A. B.
    Xin, B.
    Wong, P. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1001 - 1001
  • [2] Effect of the Direct Factor Xa Inhibitor Apixaban in Rat Models of Thrombosis and Hemostasis
    Schumacher, William A.
    Bostwick, Jeffrey S.
    Stewart, Anne B.
    Steinbacher, Thomas E.
    Xin, Baomin
    Wong, Pancras C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (06) : 609 - 616
  • [3] Antithrombotic and anticoagulant effects of direct factor Xa inhibitor darexaban in rat and rabbit models of venous thrombosis
    Kaku, Seiji
    Uemura, Toshio
    Saitoh, Minori
    Suzuki, Ken-ichi
    Iwatsuki, Yoshiyuki
    Funatsu, Toshiyuki
    Kawasaki, Tomihisa
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 699 (1-3) : 40 - 47
  • [4] Effects of the factor Xa inhibitor apixaban on venous thrombosis and hemostasis in rabbits.
    Wong, Pancras C.
    Watson, Carol A.
    Crain, Earl J.
    Luettgen, Joseph M.
    Ogletree, Martin L.
    Wexler, Ruth R.
    Lam, Patrick Y. S.
    Pinto, Donald J.
    Knabb, Robert M.
    BLOOD, 2006, 108 (11) : 275A - 275A
  • [5] Potent antithrombotic effect of a novel, small-molecule and direct inhibitor of factor XIA in prevention and treatment of thrombosis in rabbit model of arterial thrombosis at doses that preserve haemostasis
    Wong, P.
    Quan, M.
    Watson, C.
    Crain, E.
    Rendina, A.
    Luettgen, J.
    Wexler, R.
    Seiffert, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 388 - 389
  • [6] Antithrombotic effects of rivaroxaban - an oral, direct Factor Xa inhibitor - in animal models of arterial and venous thrombosis: comparison with enoxaparin, an antithrombin-dependent anticoagulant
    Perzborn, E.
    Arndt, B.
    Fischer, E.
    Harwardt, M.
    Lange, U.
    Trabandt, A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 762 - 762
  • [7] Comparative Antithrombotic and Antihemostatic Effects of the Direct Factor Xa Inhibitors, Apixaban and Rivaroxaban, and the Direct Thrombin Inhibitors, Dabigatran and Lepirudin, in Rabbit Models of Venous Thrombosis and Bleeding Time
    Wong, Pancras C.
    Crain, Earl, Jr.
    Watson, Carol
    BLOOD, 2008, 112 (11) : 1040 - 1041
  • [8] Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis
    Wang, Xinkang
    Li, Qiu
    Du, Fuyong
    Shukla, Neetu
    Nawrocki, Andrea R.
    Chintala, Madhu
    TH OPEN, 2023, 07 (02) : e97 - e104
  • [9] Antithrombotic effects of Razaxaban, an orally-active factor Xa inhibitor, in rabbit models of thrombosis.
    Wong, PC
    Watson, CA
    Crain, EJ
    Zaspel, AM
    Luettgen, JM
    Bai, SM
    Lam, PY
    Quan, ML
    Wexler, RR
    Knabb, R
    BLOOD, 2003, 102 (11) : 813A - 813A
  • [10] Antithrombotic profiles of TAK-442, a novel oral factor Xa inhibitor, in venous and arterial thrombosis models
    Konishi, N.
    Hiroe, K.
    Shinozawa, E.
    Shofuda, K.
    Matsuda, K.
    Imaeda, Y.
    Fujimoto, T.
    Kubo, K.
    Kawamura, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 759 - 760
123